Search Results
Nov 12, 2025, 04:00 ET The Marco Odermatt Capsule in Descente's New .EX Collection
S.I.O SHELL 3L JACKETStyle No: DW5FWB30MColor Code: BK99, BG99Size: F.I.D. ; 46-56 (JP;M-2XO) Marco Odermatt LIGHT INSULATED PANTSStyle No: DW5FLP32MColor Code: BK99, BG99Size: F.;38-46, I.D.;46-54, (JP;M-2XO)
More news about: DESCENTE LTD.
Nov 12, 2025, 04:00 ET La cápsula de Marco Odermatt en la nueva .EX Collection de Descente
3L JACKETEstilo No: DW5FWB30MCódigo de color: BK99, BG99Tallas: F.I.D. ; 46-56 (JP;M-2XO) Marco Odermatt LIGHT INSULATED PANTSEstilo No: DW5FLP32MCódigo de color: BK99, BG99Size: F.;38-46, I.D.;46-54, (JP;M-2XO)
More news about: DESCENTE LTD.
Nov 12, 2025, 04:00 ET La capsule Marco Odermatt dans la nouvelle collection .EX de Descente
de modèle : DW5FWB30MCode couleur : BK99, BG99Taille : F.I.D. ; 46-56 (JP ; M-2XO) Marco Odermatt LIGHT INSULATED PANTS (PANTALON ISOLANT LÉGER)Référence de modèle : DW5FLP32MCode couleur : BK99, BG99Taille : F .; 38-46, I.D. ; 46-54,
More news about: DESCENTE LTD.
Nov 10, 2025, 08:30 ET BNY to Speak at the Goldman Sachs Financial Services Conference
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that Robin Vince, Chief Executive Officer, will speak at the Goldman Sachs Financial Services Conference
More news about: BNY
Nov 06, 2025, 16:05 ET Genpact Reports Third Quarter 2025 Results
better than expected results, with another quarter of accelerating growth in Advanced Technology Solutions, up 20% year-over-year," said Balkrishan "BK" Kalra, Genpact's President and CEO. "Genpact is defining the future of Agentic Operations, rapidly integrating Advanced Technology Solutions, and
More news about: Genpact
Oct 31, 2025, 08:30 ET BNY Announces Conference Calls to Review Earnings in 2026
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, plans to report financial results and host conference calls on the following dates:
More news about: BNY
Oct 30, 2025, 08:43 ET Two-Day Online Auction by Tiger Group Features Battery Manufacturing and Lab Equipment from Natron Energy
and others by Norlake, Caron, Espec, TPS and more Large quantity assorted DC power supplies, multimeters, Hipot testers by BK Precision, Tekpower and others Shimadzu IRTracer-100 spectrophotometer, Perkin Elmer spectrometer, Mark 10 tensile tester,
More news about: Tiger Group
Oct 30, 2025, 06:30 ET Restaurant Brands International Inc. Reports Third Quarter 2025 Results
International Comparable sales accelerated to 4.0%, including 6.4% at BK International, 4.2% at TH Canada and 3.2% at BK US RBI remains on track for 8%+ organic Adjusted
More news about: Restaurant Brands International Inc.
Oct 29, 2025, 14:53 ET BNY Decreases Prime Lending Rate to 7.00%
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- BNY (NYSE: BK), will decrease the Prime Lending Rate by 0.25%, from 7.25% to 7.00%, effective Thursday, October 30, 2025.
More news about: BNY
Oct 29, 2025, 08:05 ET Genpact Recognized by Forbes as One of the World's Best Employers 2025
employers for five consecutive years reflects our commitment to our people as we become a more AI and agentic-driven company," said Balkrishan "BK" Kalra, President and CEO, Genpact. "Our culture of continuous learning and client centricity means our employees aren't just witnessing
More news about: Genpact
Oct 25, 2025, 11:00 ET BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
for multiple inflammatory pathways in disease pathogenesis. Inflamm Res. 2020;69(10):967-973. US-BK-2501221 Date of preparation: October 2025BIMZELX® is a registered trademark of the UCB Group of Companies. ©2025
More news about: UCB
Oct 23, 2025, 03:40 ET Spinogenix to Present Complete Phase 2a Clinical Trial Results for SPG601, a First-in-Class Fragile X Syndrome Treatment, at AACAP Conference
activity of large conductance, calcium-activated potassium (BK) channels, which contributes to synaptic dysfunction, cortical hyperexcitability, and multiple symptoms of FXS. SPG601, a novel small molecule, is the first positive modulator of BK channels to be clinically evaluated in FXS and has the potential
More news about: Spinogenix
Oct 17, 2025, 07:40 ET Spiber avvia una collaborazione con JNBY Group
https://mma.prnewswire.com/media/2796711/26D0028_17.jpgLogo - https://mma.prnewswire.com/media/2108564/SpiberLogo_BK_H_Logo.jpg
More news about: Spiber Inc.
Oct 16, 2025, 06:22 ET BNY Declares Dividends
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that its Board of Directors declared dividends on its common and preferred stock as follows:
More news about: BNY
Oct 16, 2025, 06:20 ET BNY Reports Third Quarter 2025 Results
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, has reported financial results for the third quarter 2025. The company's earnings release along with the quarterly
More news about: BNY
Oct 15, 2025, 12:30 ET Viven Emerges from Stealth with $35M in Funding to Bring AI Digital Twins to the Enterprise
Viven's Digital Twins, which gives our leadership team the organizational velocity to collaborate with clarity, speed, and confidence," said Balkrishan "BK" Kalra, President and CEO, Genpact. Enterprise-Grade Security and Compliance
More news about: Viven
Oct 15, 2025, 08:30 ET EquiLend's 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow
technology, data and analytics company for the securities finance industry, today announced that The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, and National Bank of Canada (TSE: NA) began executing trades utilizing 1Source's
More news about: EquiLend
Oct 15, 2025, 08:30 ET EquiLend's 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow
technology, data and analytics company for the securities finance industry, today announced that The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, and National Bank of Canada (TSE: NA) began executing trades utilizing 1Source's distributed ledger technology
More news about: EquiLend
Oct 15, 2025, 08:00 ET TIAA Wealth Management Selects BNY Pershing's Wove to Advance the Client and Advisor Experience
to the institutions and intermediaries it serves. BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Headquartered in New York City, BNY has been named among Fortune's World's Most Admired Companies and Fast Company's Best Workplaces for Innovators.
More news about: TIAA
Oct 15, 2025, 03:35 ET Spiber launches collaboration with JNBY Group
https://mma.prnewswire.com/media/2796711/26D0028_17.jpgLogo - https://mma.prnewswire.com/media/2108564/SpiberLogo_BK_H_Logo.jpg
More news about: Spiber Inc.
Sep 25, 2025, 15:01 ET Hilco Global Brings East Coast Industrial Portfolio to Market Through Bankruptcy Sale
the U.S. Bankruptcy Court, Southern District of Texas (Houston), Petition No. 9:25-bk-90165 | In re: IG Design Group Americas, Inc. Bids must be received no later than November 10, 2025, at
More news about: Hilco Global
Sep 18, 2025, 15:40 ET Orforgliprona, GLP-1 oral da Lilly, é superior à semaglutida oral em estudo head-to-head
Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, & Sloop KW, Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist, Proc. Natl. Acad. Sci. U.S.A.
More news about: Eli Lilly do Brasil
Sep 17, 2025, 16:46 ET BNY Decreases Prime Lending Rate to 7.25%
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- BNY (NYSE: BK), a global financial services company, today announced it will decrease the Prime Lending Rate by 0.25%, from 7.50% to 7.25%, effective Thursday,
More news about: BNY
Sep 17, 2025, 09:00 ET Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial
Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, & Sloop KW, Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist, Proc. Natl. Acad. Sci.
More news about: Eli Lilly and Company
Sep 17, 2025, 08:36 ET Elaris Launches: AI That Already Knows Your Audience
https://drive.google.com/drive/folders/1bK3ml4oKxpHJYDWQg648uaRkzhoD4uMt Media contact: Sebastian Weyer+4915753072551
More news about: Elaris